Stockscreener 앱 받기
11.37
0.00%
0.00
전일 마감가:
$11.37
열려 있는:
$11.34
하루 거래량:
979
Relative Volume:
0.07
시가총액:
$122.27M
수익:
-
순이익/손실:
$1.45M
주가수익비율:
-15.81
EPS:
-0.7191
순현금흐름:
$-705.90K
1주 성능:
-0.09%
1개월 성능:
+0.53%
6개월 성능:
+3.55%
1년 성능:
+7.46%
1일 변동 폭
$11.34
$11.37
1주일 범위
$11.33
$11.42
52주 변동 폭
$10.59
$11.42
Keen Vision Acquisition Corp Stock (KVAC) Company Profile
명칭
Keen Vision Acquisition Corp
전화
(203) 609-1394
주소
37 GREENBRIAR DRIVE, SUMMIT
KVAC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KVAC
Keen Vision Acquisition Corp
|
11.37 | 122.27M | 0 | 1.45M | -705.90K | -0.7191 |
|
LION
Lionsgate Studios Corp
|
5.79 | 1.91B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.33 | 702.73M | 0 | 16.92M | -1.35M | 0.29 |
|
CCCM
Columbus Circle Capital Corp I
|
10.61 | 480.62M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.50 | 468.90M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.83 | 465.53M | 0 | 1.30M | 0 | 0.0301 |
Keen Vision Acquisition Corp 주식(KVAC)의 최신 뉴스
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Large Growth in Short Interest - MarketBeat
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025 - GlobeNewswire
Toronto Dominion Bank Invests $304,000 in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 50.0% in May - MarketBeat
Polar Asset Management Partners Inc. Has $1.65 Million Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Toronto Dominion Bank Takes $304,000 Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Polar Asset Management Partners Inc. Sells 228,773 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVACWKeen Vision Acquisition Corp Latest Stock News & Market Updates - Stock Titan
Medera Showcased Positive Interim Data From First-in-Human - GlobeNewswire
Keen Vision Acquisition Corp. SEC 10-Q Report - TradingView
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress - GlobeNewswire
Boothbay Fund Management LLC Sells 52,370 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Up 33.3% in April - MarketBeat
AQR Arbitrage LLC Sells 230,549 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Berkley W R Corp Trims Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Quarry LP Lowers Stake in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 By Investing.com - Investing.com India
Keen Vision Acquisition extends merger deadline By Investing.com - Investing.com Canada
Spartan Fund Management Inc. Makes New Investment in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 - Investing.com
Keen Vision Acquisition extends merger deadline - Investing.com Australia
Medera to Go Public through Merger with KVAC - CHEManager
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 62.5% in March - MarketBeat
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of PLYA, LTRPA, MHLD, KVAC to Act Now - Morningstar
Yakira Capital Management Inc. Buys New Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.26 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.26 amid market optimism By Investing.com - Investing.com South Africa
Press Release Distribution & PR Platform - ACCESS Newswire
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Keen Vision Acquisition Corp (KVAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
1.58%
자본화:
|
볼륨(24시간):